- metadata: - source: https://trialsitenews.com/how-ivermectin-became-a-target-for-the-fraud-detectives/ - people: [[Sonia Elijah]] --- # How Ivermectin became a Target for the ‘Fraud Detectives.’ > ## Excerpt > Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. By Sonia ElijahFrom its humble --- [](https://trialsitenews.com/members/soneli/)  Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. By Sonia ElijahFrom its humble beginnings, derived from an isolated bacterial culture from Japanese soil 46 years ago, to a Nobel prize-winning and anti-parasitic drug, included in the World Health Organisation’s essential list of medicines--ivermectin is one of modern science’s major success stories. However, from the onset of the pandemic, this cheap generic drug, which for decades has safely cured people of river blindness in 33 countries, with more than 3.7 billion doses administered, has rapidly become public enemy #1 for the fact-checkers when the drug was repurposed as an early treatment and prophylaxis (preventative) for Covid-19. To date, there have been 31 RCTs (Randomized Controlled Trials), 64 controlled studies, and 7 meta-analyses of the RCTs done on ivermectin. All of them found that ivermectin significantly reduced mortality and hospitalization rates as well as the risk of contracting Covid-19. In Mexico City, over 50,000 patients were treated early with ivermectin, resulting in up to a 75% reduction in hospitalization rates, compared ... **Quality journalism costs _money to produce_**. We will be reinvesting the proceeds of these subscriptions into an increasing volume of high quality, independent, unbiased reporting and expert analysis. Our subscription tiers use the **‘honor system’**  – please do not abuse it. All tiers of service provide the same level of access to content.  We are grateful for all of you, and we hope you reciprocate. Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please [contact us](mailto:[email protected]?subject=Login%20help) or use the chat (bottom right). [](https://trialsitenews.com/members/soneli/)